These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15726646)

  • 41. Serum protein profile analysis in patients with head and neck squamous cell carcinoma.
    Gourin CG; Xia ZS; Han Y; French AM; O'Rourke AK; Terris DJ; Adam BL
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):390-7. PubMed ID: 16618908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging.
    Golizeh M; Melendez-Pena CE; Ward BJ; Saeed S; Santamaria C; Conway B; Cooper C; Klein MB; Ndao M;
    PLoS One; 2018; 13(4):e0195148. PubMed ID: 29608613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
    Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification.
    Camaggi CM; Zavatto E; Gramantieri L; Camaggi V; Strocchi E; Righini R; Merina L; Chieco P; Bolondi L
    Clin Chem Lab Med; 2010 Sep; 48(9):1319-26. PubMed ID: 20509833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
    Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma.
    Liu C; Shen J; Pan C; Yang L; Mou S; Wang H; Liang Y
    Am J Clin Pathol; 2010 Aug; 134(2):235-41. PubMed ID: 20660326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Serum proteomic profiles of the subjects with esophageal precancerous and cancerous lesions from Linzhou, an area with high incidence of esophageal cancer in Henan Province, Northern China].
    Wang LD; Wang DC; Zheng S; Fan ZM; Li JL; Feng CW; Zhang YR; Liu B; Gao SS; He X; Feng XS
    Ai Zheng; 2006 May; 25(5):549-54. PubMed ID: 16687072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients.
    Khan KN; Yatsuhashi H
    Alcohol Alcohol; 2000; 35(3):286-95. PubMed ID: 10869250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of alternative serum biomarkers to monitor the progression of chronic HBV and HCV infection.
    Tsiomita S; Georgopoulou U; Doumba PP; Koskinas J; Adamidis K; Papaloukas C; Thyphronitis G
    Infect Genet Evol; 2018 Mar; 58():17-22. PubMed ID: 29221787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum peptide profiles during progression of chronic hepatitis B virus infection to liver failure.
    Han T; Liu H; Yu ZL; Li J; Wang L; Xiao SX; Li Y; Yu ML
    J Viral Hepat; 2010 Mar; 17 Suppl 1():18-23. PubMed ID: 20586930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
    Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
    Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
    Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased expression and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus.
    Kuramitsu Y; Harada T; Takashima M; Yokoyama Y; Hidaka I; Iizuka N; Toda T; Fujimoto M; Zhang X; Sakaida I; Okita K; Oka M; Nakamura K
    Electrophoresis; 2006 Apr; 27(8):1651-8. PubMed ID: 16609938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.